Groundbreaking research published in Science Translational Medicine has identified distinct immune system changes and RNA expression patterns that predict which precancerous colorectal lesions will progress to cancer. The discovery represents a significant advance in early detection and prevention strategies for colorectal cancer, currently the third leading cause of cancer deaths worldwide.
The study demonstrates that alterations in the immune microenvironment occur during the earliest stages of colorectal carcinogenesis, well before visible malignant changes become apparent. These immune changes create a permissive environment for malignant transformation, opening new avenues for therapeutic intervention. By combining immune and RNA profiling, clinicians may soon identify high-risk patients requiring intensive surveillance, fundamentally transforming how we approach colorectal cancer prevention and early detection.
Read the full article on GMJ Newsroom.
Was this article helpful?
